Current Neuropharmacology

Papers
(The TQCC of Current Neuropharmacology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease233
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach119
Crosstalk between Inflammation and the BBB in Stroke75
Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke67
Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases64
A Scientometrics Analysis and Visualization of Depressive Disorder55
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective55
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled49
Alzheimer’s Disorder: Epigenetic Connection and Associated Risk Factors47
‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports47
The Potential Role of Dysfunctions in Neuron-Microglia Communication in the Pathogenesis of Brain Disorders46
Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition45
Selenium and Neurological Diseases: Focus on Peripheral Pain and TRP Channels41
Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease41
Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia41
The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke40
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications40
The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target37
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress37
Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation37
PTSD in the COVID-19 Era34
The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms34
Potential Mechanisms and Clinical Effectiveness of Acupuncture in Depression33
Exosomes as a Promising Therapeutic Strategy for Peripheral Nerve Injury32
Neuroprotective Polyphenols: A Modulatory Action on Neurotransmitter Pathways31
The Role of Autophagy in the Pathogenesis of Ischemic Stroke31
A New Vision of Mitochondrial Unfolded Protein Response to the Sirtuin Family30
Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review30
5-HT3 Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders30
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease29
Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development28
Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease28
Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer’s Disease28
Underlying Mechanisms and Potential Therapeutic Molecular Targets in Blood-Brain Barrier Disruption after Subarachnoid Hemorrhage28
The Effects of General Anesthetics on Synaptic Transmission27
Management Perspective of Wilson’s Disease: Early Diagnosis and Individualized Therapy27
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases27
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19- induced Damage to the Nervous System27
Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)26
Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia25
Depression and Pain: Use of Antidepressants25
The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection25
Therapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease25
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperact24
Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders24
Traumatic Brain Injury: A Forensic Approach: A Literature Review23
Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry23
New Mechanisms and Targets of Subarachnoid Hemorrhage: A Focus on Mitochondria23
Acid-Sensing Ion Channels: Focus on Physiological and Some Pathological Roles in the Brain22
cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases22
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor21
Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine21
Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders20
Neurodegenerative Pathways in Alzheimer’s Disease: A Review19
An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants19
Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy19
Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation19
The Links between Cardiovascular Diseases and Alzheimer's Disease19
Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases19
Emerging Evidence for Neuropsycho-Consequences of COVID-1919
The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies19
Neural Substrates for the Regulation of Sleep and General Anesthesia19
SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan19
Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease18
Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression18
Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences18
Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease18
Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link17
PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer’s Disease17
Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A Multimodal Therapeutic Target in Traumatic Brain Injury17
Circadian Rhythm Disruption and Alzheimer’s Disease: The Dynamics of a Vicious Cycle17
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update17
MicroRNAs in the Blood-Brain Barrier in Hypoxic-Ischemic Brain Injury16
Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives16
Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy16
Tyrosol as a Neuroprotector: Strong Effects of a “Weak” Antioxidant16
The Dawn of Mitophagy: What Do We Know by Now?16
From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod16
Nerve Growth Factor in Alcohol Use Disorders16
Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease16
Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk16
Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches16
The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention15
Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights15
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment15
The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic Cannabinoids’ Information Available Online15
Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-1915
Effects of General Anesthetics on Synaptic Transmission and Plasticity15
Targeting Brain-spleen Crosstalk After Stroke: New Insights Into Stroke Pathology and Treatment15
Chlorogenic Acid Improves PTSD-like Symptoms and Associated Mechanisms15
Neuroprotective Effects of Neuropeptide Y against Neurodegenerative Disease15
Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy15
Xenogeneic Decellularized Extracellular Matrix-based Biomaterials For Peripheral Nerve Repair and Regeneration14
Adolescent Substance Abuse, Transgenerational Consequences and Epigenetics14
Effects of Histone Modification in Major Depressive Disorder14
The Brain-gut Axis-where are we now and how can we Modulate these Connections?14
A Comprehensive Review of Alzheimer’s Association with Related Proteins: Pathological Role and Therapeutic Significance14
Association of Oxidative Stress with Neurological Disorders14
Adult Neurogenesis in Epileptogenesis: An Update for Preclinical Finding and Potential Clinical Translation14
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review14
Is It the Twilight of BACE1 Inhibitors?14
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations14
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors14
Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain14
Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update14
Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmac14
Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease13
Repetitive Transcranial Magnetic Stimulation Combined with Antidepressants for the First Episode of Major Depressive Disorder13
Role of Grina/Nmdara1 in the Central Nervous System Diseases13
Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders13
A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects13
Novel Synthetic and Natural Therapies for Traumatic Brain Injury13
Challenges of Delirium Management in Patients with Traumatic Brain Injury: From Pathophysiology to Clinical Practice13
Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review12
Pharmacologic Treatment of Restless Legs Syndrome12
Green Tea, A Medicinal Food with Promising Neurological Benefits12
The Complexity of Secondary Cascade Consequent to Traumatic Brain Injury: Pathobiology and Potential Treatments12
Evaluation of Anti-inflammatory Nutraceuticals in LPS-induced Mouse Neuroinflammation Model: An Update12
Neurochemical and Behavioral Consequences of Ethanol and/or Caffeine Exposure: Effects in Zebrafish and Rodents12
Effects of Di-2-Ethylhexyl Phthalate on Central Nervous System Functions: A Narrative Review12
Phytochemicals Targeting Oxidative Stress, Interconnected Neuroinflammatory, and Neuroapoptotic Pathways Following Radiation12
Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis12
BACE1: A Key Regulator in Alzheimer’s Disease Progression and Current Development of its Inhibitors12
Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases12
Current and Emerging Treatments for Methamphetamine Use Disorder12
Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art12
Targeting Glioblastoma: The Current State of Different Therapeutic Approaches12
Hydrogen Sulfide (H2S) Signaling as a Protective Mechanism against Endogenous and Exogenous Neurotoxicants12
The Emerging Role of the Double-Edged Impact of Arachidonic Acid- Derived Eicosanoids in the Neuroinflammatory Background of Depression.12
Protective Effects of Dendrobium nobile Lindl. Alkaloids on Alzheimer's Disease-like Symptoms Induced by High-methionine Diet12
Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis12
Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?11
Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli11
Pathways Involved in Remyelination after Cerebral Ischemia11
Immune Checkpoint Inhibitors and Neurotoxicity11
Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach11
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases11
Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools11
Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders11
Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study10
Neurodevelopment Following Exposure to Antiseizure Medications in Utero: A Review10
Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation10
Sceletium for Managing Anxiety, Depression and Cognitive Impairment: A Traditional Herbal Medicine in Modern-Day Regulatory Systems10
Early Biomarkers and Intervention Programs for the Infant Exposed to Prenatal Stress10
Cholinesterase Inhibitory Potential of Quercetin towards Alzheimer’s Disease - A Promising Natural Molecule or Fashion of the Day? - A Narrowed Review10
Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease10
Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update10
Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications10
Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives10
Microtubule-modulating Agents in the Fight Against Neurodegeneration: Will it ever Work?10
The Potential Role of Hypoxia-Inducible Factor-1 in the Progression and Therapy of Central Nervous System Diseases10
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases10
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study9
Crocus Sativus L. (Saffron) in Alzheimer’s Disease Treatment: Bioactive Effects on Cognitive Impairment9
Voxel-wise Functional Connectivity of the Default Mode Network in Epilepsies: A Systematic Review and Meta-Analysis9
The Investigation into Neurotoxicity Mechanisms of Nonylphenol: A Narrative Review9
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease9
Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease9
The Benzydamine Experience: A Systematic Review of Benzydamine Abuse9
C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside9
Pharmacological Strategy for Congenital Myasthenic Syndrome with CHRNE Mutations: A Meta-Analysis of Case Reports9
Protective Effects of Polydatin Against Dementia-Related Disorders9
Cholinergic Modulation of General Anesthesia9
Effects of Mulberry on The Central Nervous System: A Literature Review9
The Role of Astrogliosis in Formation of the Syrinx in Spinal Cord Injury9
Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis9
The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease9
What About Drug Checking? Systematic Review and Netnographic Analysis of Social Media9
Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic Review9
Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease9
Melatonin as a Chronobiotic with Sleep-promoting Properties9
Putative Roles of Astrocytes in General Anesthesia9
The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review9
Depression: An Insight into Heterocyclic and Cyclic Hydrocarbon Compounds Inspired from Natural Sources9
Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy9
Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance9
Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas9
The Protective Roles and Molecular Mechanisms of Troxerutin (Vitamin P4) for the Treatment of Chronic Diseases: A Mechanistic Review9
0.033555030822754